Kansas City Cannabis, one of the few 100% Missouri owned and operated medical marijuana dispensary license winners, has announced the Grand Opening of their Kearney, MO location on Saturday, June 12, from 11am – 7pm.

The company’s “Patients First” Program features an extensive list of stackable discounts, including a special First-Time Purchase discount of 20% for all attendees. Kansas City Cannabis recently made Missouri cannabis industry history by bringing Full Extract Cannabis Oil (FECO) to the market with their partners at CoCo Labs. FECO medicine is the most sought after treatment for severely ill Patients undergoing cancer treatments and other debilitating conditions. CoCo Labs and Kansas City Cannabis are providing FECO at manufacturing cost for Patients with $0 markup.

Additionally, the first 50 patients through the doors will take home a gift bag full of goodies, coupons, and accessories so attendees are encouraged to show up early! A full list of discounts, menu and other benefits included with the Patients First Program can be found by visiting KCCannabis.org.

Kevin Stallings, CEO, said, “Kansas City Cannabis Company is committed to providing only the best cannabis products available with a clear focus on health, wellness and education to improve the quality of life for our patients and our community. We can’t wait to welcome you to our new facility!”

Kansas City Cannabis Company was founded in the fall of 2018 by a passionate group of advocates determined to redefine the MMJ patient experience. After more than two years of planning, investments, and construction, the team is proud to open its doors to the patients of Missouri. Highly-trained and knowledgeable staff will be ready to help guide patients to the products and services needed to achieve their health and wellness goals.

The Kansas City Cannabis Company is located at 310 Platte Clay Way in Kearney.

The grand opening Saturday, June 12th from 11am-7pm and will feature a free BBQ lunch from 11:30am – 2:30pm.

KPGZ News - Brian Watts contributed to this story